JPRN-UMIN000001925CompletedPhase 2
Effects of ghrelin administration after total gastrectomy in patients with gastric cancer: A prospective randomized placebo-controlled phase II study - Effects of ghrelin administration after total gastrectomy in patients with gastric cancer: A prospective randomized placebo-controlled phase II study
Osaka University School of Medicine Gastroenterological Surgery0 sites20 target enrollmentStarted: May 1, 2009Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 20
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 80years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The exclusion criteria were the presence of any of the following; 1) cardiopulmonary, liver or renal dysfunction, 2) active dual malignancy, 3) pregnancy, 4) past history of gastrointestinal surgery, 5) postoperative complications after TG that could affect oral food intake, such as anastomotic leakage, pancreatitis and ileus.
Investigators
Similar Trials
Completed
Not Applicable
Effects of ghrelin administration after gastrectomy in patients with gastric cancer: phase II studyGastric cancer patients who underwent gastrectomyJPRN-UMIN000008683Osaka University School of Medicine Gastroenterological Surgery10
Completed
Phase 2
Clinical trial of ghrelin administration after esophagectomy with gastric tube reconstruction in early postoperative period.esophageal cancerJPRN-UMIN000003299Department of Gastroenterological Surgery, Department of Surgery, Graduate School of Medicine, Osaka University10
Unknown
Not Applicable
Clinical trial of ghrelin administration in patients with chronic obstructive pulmonary diseaseChronic obstructive pulmonary diseaseJPRN-C000000061ational Cardiovascular Center Research Institute60
Completed
Not Applicable
A Dose-Response Study of Human Unacylated Ghrelin on Glycemia during Oral Glucose Tolerance Test in Patients with Type 2 Diabetes Mellitusinsulin sensitivity10018424diabetesNL-OMON34644Erasmus MC, Universitair Medisch Centrum Rotterdam12
Completed
Not Applicable
Symptomatic effect and serum gastrin level after treatment with proton pump inhibitor in GERD investigation in partial responder to potassium-competitive acid blockerGERDJPRN-UMIN000030941Ishihara Gastroenterology Clinic25